Literature DB >> 21115728

IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression.

Kathrin Eller1, Dominik Wolf, Julia M Huber, Martin Metz, Gert Mayer, Andrew N J McKenzie, Marcus Maurer, Alexander R Rosenkranz, Anna M Wolf.   

Abstract

Both mast cells (MCs) and regulatory T cells (Tregs) have gained attention as immunosuppressive cell populations. To investigate a possible interaction, we used the Th1- and Th17-dependent model of nephrotoxic serum nephritis (NTS), in which both MCs and Tregs have been shown to play a protective role. Transfer of wild-type (wt) Tregs into wt recipients almost completely prevents development of NTS and leads to a profound increase of MCs in the renal draining lymph nodes (LNs). By contrast, transfer of wt Tregs into animals deficient in MCs, which are characterized by an exaggerated susceptibility to NTS, no longer exhibited protective effects. Blocking the pleiotropic cytokine IL-9, known to be involved in MC recruitment and proliferation, by means of a mAb in mice receiving Tregs abrogated protection from NTS. Moreover, transfer of IL-9-deficient Tregs also failed to protect from NTS. In the absence of Treg-derived IL-9, MCs fail to accumulate in the LNs, despite the fact that IL-9 deficiency does not alter the general suppressive activity of Tregs. In summary, to our knowledge, we provide the first direct in vivo evidence that the nephroprotective, anti-inflammatory effects of Tregs critically depend on IL-9-mediated attraction of MCs into kidney-draining LNs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115728      PMCID: PMC3227733          DOI: 10.4049/jimmunol.1001183

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B.

Authors:  Michele A Grimbaldeston; Susumu Nakae; Janet Kalesnikoff; Mindy Tsai; Stephen J Galli
Journal:  Nat Immunol       Date:  2007-09-02       Impact factor: 25.606

2.  Mast cells in rapidly progressive glomerulonephritis.

Authors:  T Tóth; R Tóth-Jakatics; S Jimi; M Ihara; H Urata; S Takebayashi
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

3.  Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo.

Authors:  Michele A Grimbaldeston; Ching-Cheng Chen; Adrian M Piliponsky; Mindy Tsai; See-Ying Tam; Stephen J Galli
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

4.  Tubulointerstitial mast cell infiltration in glomerulonephritis.

Authors:  K Hiromura; M Kurosawa; S Yano; T Naruse
Journal:  Am J Kidney Dis       Date:  1998-10       Impact factor: 8.860

5.  Regulatory CD25+ T cells in human kidney transplant recipients.

Authors:  Alan D Salama; Nader Najafian; Michael R Clarkson; William E Harmon; Mohamed H Sayegh
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

6.  CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.

Authors:  Oliver M Steinmetz; Jan-Eric Turner; Hans-Joachim Paust; Matthias Lindner; Anett Peters; Kirstin Heiss; Joachim Velden; Helmut Hopfer; Susanne Fehr; Thorsten Krieger; Catherine Meyer-Schwesinger; Tobias N Meyer; Udo Helmchen; Hans-Willi Mittrücker; Rolf A K Stahl; Ulf Panzer
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

7.  Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Authors:  Marc Veldhoen; Catherine Uyttenhove; Jacques van Snick; Helena Helmby; Astrid Westendorf; Jan Buer; Bruno Martin; Christoph Wilhelm; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

Review 8.  The enigmatic role of mast cells in dominant tolerance.

Authors:  Victor C de Vries; Karina Pino-Lagos; Raul Elgueta; Randolph J Noelle
Journal:  Curr Opin Organ Transplant       Date:  2009-08       Impact factor: 2.640

Review 9.  Human T regulatory cell therapy: take a billion or so and call me in the morning.

Authors:  James L Riley; Carl H June; Bruce R Blazar
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

10.  Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.

Authors:  S Read; V Malmström; F Powrie
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  85 in total

1.  Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells.

Authors:  Wassim Elyaman; Ribal Bassil; Elizabeth M Bradshaw; William Orent; Youmna Lahoud; Bing Zhu; Freddy Radtke; Hideo Yagita; Samia J Khoury
Journal:  Immunity       Date:  2012-04-12       Impact factor: 31.745

Review 2.  Immune mediators of chronic pelvic pain syndrome.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Nat Rev Urol       Date:  2014-04-01       Impact factor: 14.432

Review 3.  IL-9 and Th9 cells: progress and challenges.

Authors:  Picheng Zhao; Xiang Xiao; Rafik M Ghobrial; Xian C Li
Journal:  Int Immunol       Date:  2013-09-11       Impact factor: 4.823

Review 4.  Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer.

Authors:  Carole A Oskeritzian
Journal:  Mol Immunol       Date:  2014-04-22       Impact factor: 4.407

Review 5.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

Authors:  Taku Kambayashi; Terri M Laufer
Journal:  Nat Rev Immunol       Date:  2014-10-17       Impact factor: 53.106

Review 6.  Heterogeneity and Stability in Foxp3+ Regulatory T Cells.

Authors:  Booki Min
Journal:  J Interferon Cytokine Res       Date:  2017-07-11       Impact factor: 2.607

7.  Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation.

Authors:  Arijita Jash; Anupama Sahoo; Gi-Cheon Kim; Chang-Suk Chae; Ji-Sun Hwang; Jung-Eun Kim; Sin-Hyeog Im
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

Review 8.  Regulatory roles of mast cells in immune responses.

Authors:  Hideaki Morita; Hirohisa Saito; Kenji Matsumoto; Susumu Nakae
Journal:  Semin Immunopathol       Date:  2016-05-06       Impact factor: 9.623

9.  Cloning and functional testing of rhesus macaque (Macaca mulatta) IL-9 and IL-33.

Authors:  Sanghita Sarkar; Ann J Hessell; Nancy L Haigwood; James J Kobie
Journal:  J Med Primatol       Date:  2020-02-04       Impact factor: 0.667

10.  Th9 cells promote antitumor immune responses in vivo.

Authors:  Yong Lu; Sungyoul Hong; Haiyan Li; Jungsun Park; Bangxing Hong; Lijuan Wang; Yuhuan Zheng; Zhiqiang Liu; Jingda Xu; Jin He; Jing Yang; Jianfei Qian; Qing Yi
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.